Esr1-mutant Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-03
Clinical Trial Update: Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. [Phase 3]
A Phase 3 trial evaluating the combination of elacestrant and everolimus in ER-positive, HER2-negative advanced breast cancer with ESR1 muta…